evidence of effectiveness on visual attention: ABSTRACT Using a pretest and posttest comparison group design, this 20 weeks study investigated the effects of a phonological awareness training program (PATP) on attention efficiency (AE) in 57 children (age = 5 to 6 years) at risk. The experimental group received the PATP (EG; n=30). We obtained pretest and posttest measures of phonological awareness and AE. The ANOVA showed significant interaction effects of the PATP and time on phonological awareness and AE. For both groups, posttest AE score means were higher than pretest score means. Pretest measures showed that the AE score mean for the EG was lower than that for the Control Group (CG; n=31); whereas posttest data showed no between group differences. Contrast analysis showed that the EG gained a greater level of phonological awareness ability and AE over CG. Our results indicate that children’s attention efficiency not only improved as they developed, but also increased by means of a PATP.
http://ift.tt/2agyHAv
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Delivered-To: alsfakia@gmail.com Received: by 2002:a4a:1484:0:0:0:0:0 with SMTP id 126csp3276540ood; Sun, 15 Nov 2020 22:05:16 -0...
-
ICHD-3 beta Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Di...
-
Abstract Owing to the functional versatility and potential applications in industry, interest in lipolytic enzymes tolerant to organic sol...
-
Abstract Objective Tooth agenesis is one of the most common craniofacial developmental anomalies. In hypodontia, one to five teeth are m...
-
Editor's Note In "Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse ...
-
AbstractBackground Recent evidence suggests that bioresorbable vascular scaffolds (BVS) are associated with an excess of thrombotic complic...
-
Abstract Background Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is the optimal treatment for EGFR-mutant advance...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου